2-(Pyridin-4-yl)pyrimidine-5-carbonitrile

Catalog No.: 
ACCFOC891
CAS No.: 
1158735-19-3
Molecular Formula: 
C10H6N4
Molecular Weight: 
182.19
2-(Pyridin-4-yl)pyrimidine-5-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$209.00InquiryInquiry
1g97%$615.00InquiryInquiry
5g97%$3044.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Pyridin-4-yl)pyrimidine-5-carbonitrile
IUPAC Name2-(pyridin-4-yl)pyrimidine-5-carbonitrile
Molecular FormulaC10H6N4
Molecular Weight182.19
SMILESN#CC1=CN=C(C2=CC=NC=C2)N=C1
InChI KeyCDMCYZSCFJVBSQ-UHFFFAOYSA-N
Synonym2-(PYRIDIN-4-YL)PYRIMIDINE-5-CARBONITRILE;5-Pyrimidinecarbonitrile, 2-(4-pyridinyl)-
CAS No.1158735-19-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCFOC891 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGOVS347 route compound structure diagram
    ACGOVS3471753-50-0In Stock
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1In Stock
  4. Then
  5. ACCFOC891 route product structure diagram
    ACCFOC8911158735-19-3
Inquiry

2. ACCFOC891 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKNPF378 route compound structure diagram
    ACKNPF378181219-01-2In Stock
  2. Plus
  3. ACGOVS347 route compound structure diagram
    ACGOVS3471753-50-0In Stock
  4. Then
  5. ACCFOC891 route product structure diagram
    ACCFOC8911158735-19-3
Inquiry

3. ACCFOC891 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCFOC891 route product structure diagram
    ACCFOC8911158735-19-3
Inquiry

Comments (0)